New studies show that pharmacological treatment with GLP-1-RA and dual GLP-1/glucose-dependent insulinotropic polypeptide receptor agonists (GIP-RA) cause almost as much weight loss as gastric surgery ...

Millions of people taking semaglutide or tirzepatide for weight loss could be losing more than fat. A pharmacovigilance study ...

Diabetes and obesity have become pressing health issues worldwide. Glucagon-like peptide-1 (GLP-1) receptor agonists, a class of medications widely used in the treatment of type 2 diabetes (T2D), have ...

Weight-loss drugs like semaglutide may melt fat, but at the cost of muscle mass. A new review reveals how to protect your strength while reaping the benefits. Study: Glucagon-like peptide-1 receptor ...

Retatrutide is being hailed as a “trillion-dollar” weight-loss breakthrough that also spares muscle. Is this really the holy ...

With glucagon-like peptide 1 (GLP-1) agonists now close to inducing weight loss at levels only seen before through surgical intervention, obesity specialists say patients on these drugs are ...

Obesity and dietitian societies have joined forces to issue a new consensus statement on recommendations surrounding the use ...

Share on Pinterest Research is looking for ways to minimize muscle loss from GLP-1 drugs taken to treat obesity. Iuliia Burmistrova/Getty Images GLP-1 drugs have helped people successfully achieve and ...

Medicare has expanded access to GLP-1 weight-loss medications. These drugs may also help treat addiction. Primary care ...